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Abstract 
Determination of muscle mass, fat mass and body water. Is bioimpedance with 
Impedimed SFB7 consistent with reference methods? 
 
Jakob Nilsson 
 
Degree project, Programme in Medicine, 2016, Department of Internal Medicine and 
Clinical Nutrition, Sahlgrenska Academy at University of Gothenburg, Sweden. 
  
Background: Malnutrition and fluid imbalance are common among hospitalized 
patients. Bioimpedance is a manageable and inexpensive method to estimate Total 
Body Skeletal Muscle Mass (TBSMM), Fat Mass (FM), Total Body Water (TBW), 
Extracellular Water (ECW) and Intracellular Water (ICW). However, further 
validations against reference methods are required before introducing it to everyday 
use in clinical practise.   
 
Aim: To validate SFB7 bioimpedance device’s ability to measure TBSMM, FM, 
TBW, ECW and ICW against reference methods in healthy subjects.  
 
Methods: 50 healthy adults (men, n=25; women, n=25) were measured with SFB7 
and reference methods: Dual-energy X-ray Absorptiometry (DXA), Air Displacement 
Plethysmography (ADP), Dilution Techniques and Total Body Potassium (TBK). 
Paired-Samples T-Test, linear regression and Bland Altman plots were used to 
compare SFB7 estimates for TBSMM, FM, TBW, ECW and ICW with reference 
methods.     
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Results: The correlations between estimates by SFB7 and reference methods in men 
were high for TBSMM (rP=0.914) and ECW (rP=0.931), however significant 
differences in mean and systematic bias were found in both variables. The 
correlations between SFB7 and reference methods for FM, TBW and ICW were not 
impressive.  
 
The correlations between estimates by SFB7 and reference methods in women were 
high for FM (rPDXA=0.898, rPADP=0.890) and ECW (rP=0.907). SFB7 underestimated 
FM and overestimated ECW significantly. The correlations between estimates by 
SFB7 and reference methods for TBSMM, TBW and ICW were not impressive. 
 
Conclusions: Bioimpedance by Impedimed SFB7 by proprietary software and 
equations does not correctly predict TBSMM, FM, TBW, ECW and ICW in healthy 
men and women. 
 
Key words: Bioimpedance; body water; total body skeletal muscle mass; fat mass; 
validation  	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Background 
Malnutrition is a condition where a deficiency or imbalance of energy, protein and 
other nutrients has caused measurable and adverse changes in body composition, 
function or an individual's course of disease (1). 
 
Malnutrition is common among hospitalized patients globally, as well in Europe (2), 
Asia (3, 4), Australia (5), Africa (6, 7) and America (8, 9). It results in high costs (10), 
longer hospitalization and correlate with infections and worse prognoses (11, 12). 
Considerable loss of body cell mass as a result of inadequate nutritional therapy has 
been seen in patients in surgical gastrointestinal and orthopaedic wards (13). Parts of 
the problem tend to be lack of physician awareness (12) and education (13). A Danish 
study shows that patients at nutritional risk rarely are evaluated regarding nutrition 
and therefore lack proper planning and monitoring (14).    
 
There are several screening tools to detect malnutrition recommended by The 
European Society of Clinical Nutrition and Metabolism (ESPEN) (15). Malnutrition 
Universal Screening Tool (MUST) investigate the presence of malnutrition based on 
Body Mass Index (BMI), unplanned weight loss and presence of acute disease (16). 
Nutritional Risk Screening 2002 (NRS-2002) takes BMI, percent recent weight loss, 
change in food intake, severity of disease and age into account (17). The Mini 
Nutritional Assessment (MNA) takes height/weight, weight loss, questions related to 
lifestyle, medications, mobility and food intake as well as the patients subjective 
evaluation of his or hers health and nutrition into consideration (18).        
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Meanwhile almost 40 % of the adult population is considered either overweight or 
obese (19).  
 
BMI is a simple method to classify underweight, overweight and obesity in adults. 
Body weight in kilograms is divided by the square height in metres (kg/m2).  
Underweight is defined as BMI < 18.5, normal range is defined as BMI 18.5 – 24.99, 
overweight is defined as BMI ≥ 25 and obese is defined as BMI ≥ 30 (20). However, 
BMI does not say to what extent the weight consists of fat, muscles or fluids, 
increasing the need for more precise methodology for determination of body 
composition (21).  
 
Dehydration is also common among hospitalized patients and correlates with poor 
outcomes, such as death (22, 23). Fluid overload is seen among patients with dialysis 
(24), decompensated heart failure (25) and septic chock (26). Fluid overload in 
dialysis patients is associated with higher risk of cardiovascular death (27). In acute 
conditions, it may lead to pulmonary oedema (28).  
 
Hydration can be approximated by repeated body weight measurements (29), blood 
tests (haemoglobin, haematocrit, electrolytes and urea-to-creatinine ratio), urine 
samples (osmolality, electrolytes, fluid rate) and clinical observations (blood 
circulation, skin turgor and pitting oedema) (30).  
 
Body composition can be described in different ways. Body weight can be defined as 
fat mass (FM) + fat free mass (FFM), where FFM on a molecular level includes 
water, proteins, glycogen, minerals and essential lipids. On a cellular level total body 
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water (TBW) is divided into intracellular water (ICW) and extracellular water (ECW). 
On a tissue-system level BW can be divided into adipose tissue, skeletal muscle, 
bone, viscera and blood. Body composition can also be described on an atomic level 
and a whole body level, the latter concerning body size, shape, exterior and physical 
characteristics (31).         
 
Anthropometry comprises several classical ways to measure a subject, including 
simply measuring height and body weight. Different body parts breadths, 
circumferences and areas are also of interest as well as skinfold thickness and body 
volume (32).  
  
In addition, there are more resource-demanding methods to measure body 
composition. Imaging techniques such as magnetic resonance imaging (MRI) and 
computerized tomography (CT) are considered the most accurate. Neutron activation 
is a highly valued method where tissues are depicted by a measurable decay product 
arisen when exposing chemical elements to a neutron flux. However, these methods 
require very expensive equipment and are limited to research applications. In 
addition, CT and Neutron activation exposes the subject to radiation (33). Air 
Displacement Plethysmography (ADP), Dual-energy X-ray absorptiometry (DXA), 
Dilution Techniques, Whole body counting for Total Body Potassium (TBK) and 
bioimpedance are other methods (32).                   
 
ADP, a form of densitometry, estimates body volume by calculations of the pressure 
changes that occur when a subject is put in a closed chamber. By also weighing the 
subject the density will be given. FM can be derived from the density (34).        
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For DXA measurements, X-rays with two discrete photon energy levels pass through 
the body. Different tissues have different attenuation for each energy level, hence the 
remaining photons measured by detectors after passage will reflect an image of body 
composition. DXA divides the body into three components: FM, bone mineral (BMC) 
and lean soft tissue mass (LSTM) (35). Equations based on LSTM on arms and legs, 
called appendicular lean soft tissue (ALST), predominantly consisting of muscles, are 
used to predict Total Body Skeletal Muscle Mass (TBSMM) (36).     
 
Dilution Techniques can measure TBW and ECW. To measure TBW the subject is 
administered a specific amount of labelled water (e.g. tritium (3H)). To measure ECW 
the subject is administered a specific amount of bromide (Br) ions. The tracers (3H 
and Br) will distribute in each intended compartment. The concentration of 3H and Br 
in blood after an equilibration time will provide the volume of TBW and ECW by 
Fick’s dilution principle (c1V1=c2V2) (32). ICW is obtained by subtracting ECW from 
TBW (31).     
 
TBK is measured using a whole-body counter. The whole-body counter uses the fact 
that radioactive 40K, natural existent in the body, decays producing gamma rays. A 
detector system intercepts the gamma rays and a value for TBK can further be derived 
from the activity of 40K in the body (32). 98% of all potassium is located within the 
cells (37). Body cell mass (BCM), consisting of muscle mass, visceral organs, blood 
and brain can be derived from TBK (32). BCM can be recalculated to ICW (38).    
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Bioimpedance measures TBW and ECW by allowing an alternating current to pass 
through the body water at different frequencies. The current will encounter 
impedance: a combination of resistance and reactance (capacitance arisen from cell 
membranes). At zero frequencies the current does not penetrate the cell membranes, 
thus giving a value for ECW. At high frequencies the current on the contrary does 
penetrate the cell membranes, providing a value for both ECW and ICW together 
becoming TBW (39). Equations to estimate total body skeletal muscle mass 
(TBSMM) (40), FM and FFM (41) have been developed.        
 
Dilution Techniques, whole body counting for TBK, ADP and DXA are considered 
reference methods in this context (39). However, they have several drawbacks. The 
methods would not allow bedside measurements. Whole-body counters are expensive 
and difficult to access. Dilution Techniques are invasive and require advanced 
equipment for analysis. DXA and dilution with labelled water expose the subject to 
radiation (32). For these reasons, interest has been directed towards measurements, 
which allows inexpensive, non-invasive, manageable bedside measurement where test 
results can be obtained quickly. However bioimpedance, being an indirect method 
requires predictive equations, which has its weaknesses (39, 42).    
 
Measurement with bioimpedance has been shown to be consistent with reference 
methods regarding body water in healthy individuals (43, 44), including changes in 
ECW during both dehydration and rehydration (45). Bioimpedance is able to estimate 
FM (46) as well as Subcutaneous Adipose Tissue (SAT) and skeletal muscle mass in 
haemodialysis patient, indicating that it could be used to assess nutritional status (47).  
However, bioimpedance lack the ability to estimate TBW and ECW in the overweight 
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and obese (48) as well as in patients undergoing severe weight loss due to gastric 
reduction surgery (49). Estimating errors have been seen among patients with cancer 
(50), haemodialysis (51), other internal medicine disorders (52) and gastrointestinal 
conditions (53). Whilst bioimpedance may provide values consistent with reference 
methods at a group level, individual differences may occur, as seen in end-stage renal 
disease patients (54).      
 
In this study, we aimed to investigate if previous corresponding values between 
bioimpedance and reference methods (Dilution Techniques, TBK) for estimating 
body water in healthy individuals were reproducible when using an Impedimed SFB7 
bioimpedance device (Impedimed SFB7, Australia), further referred to as SFB7. We 
also aimed to compare the ability of SFB7 to measure TBSMM compared to DXA, 
using external predictive equations. Furthermore we aimed to compare the FM 
estimate provided by SFB7 with DXA and ADP.  The study was meant to serve as 
pilot study for possible further research in the ill. 
Aim and research questions 
Aim 
To validate SFB7’s ability to determine TBSMM, FM, TBW, ECW and ICW in 
healthy subjects in comparison with reference methods (DXA, ADP, 3H/Br-dilution, 
TBK).     
Research questions 
• Will SFB7 provide values for TBSMM consistent with DXA? 
• Will SFB7 provide values for FM consistent with DXA and ADP?  
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• Will SFB7 provide values for TBW consistent with 3H-dilution?  
• Will SFB7 provide values for ECW consistent with Br-dilution? 
• Will SFB7 provide values for ICW consistent with Dilution Techniques and 
whole body counting for TBK?    
Material and Methods 
Population and data collection 
During the fall of 2016 volunteers were asked orally or by posting to participate in 
this study. Posters were pinned to billboards at the University of Gothenburg and 
Chalmers university of Technology in Sweden. Between October 6th and November 
14th 2016, 50 healthy subjects over the age of 20, divided in 25 men and 25 women 
had their body composition measured by SFB7, Dilution Techniques, DXA, ADP and 
whole body counting for TBK. Healthy was defined as the absence of symptoms and 
regular medication. People with claustrophobia were excluded because of the narrow 
spaces entailed by the whole body counter and the ADP. Pregnant females were 
excluded because of the exposure to radiation.  
People with BMI > 34kg/m2 or < 16kg/m2 were excluded because of the 
bioimpedance’s minor ability to measure these (42).            
Measurements 
Each subject performed all five measurements at the same occasion, over a period of 
3.5 hours. The subjects attended the laboratory in the morning, after an overnight fast. 
Body weight was measured with the subjects in their underwear to the nearest 0.1kg 
using an electronic balance. Height was measured with a stadiometer to the nearest 
0.1cm.  
	   13	  
 
Dilution Techniques. A baseline urine sample, 5-10 ml, was collected, whereupon the 
subject drank a solution containing 1ml 3.7MBq/ml 3H, radiation dose 0.07mSv and 
45ml 5% sodium bromide (NaBr). A postdose blood sample, 9ml, was collected 3 
hours after the oral dose. The baseline urine sample was used to subtract possible 
natural occurring 3H and Br from the postdose blood sample.     
 
The serum was centrifuged. Approximately 2 ml serum was sublimated to separate 
H2O and 3H from other molecules (proteins, ions etc.). 0.5 ml sublimate + 0.5 ml 
standard solution (plasma, 3H 3.7MBq/ml, 1:40 000 diluted) were analysed in a Tri-
Carb liquid scintillation counter. TBW was calculated as: 
 
TBW3H (L) = 
Dose × 40 000 × (Std. count – blank count)
1000 × (Serum count-Urine count)
    (1) 
where Dose = Amount (in ml) of test solution administered, 40 000 = Standard 
solution dilution factor, Std. count = Activity in standard solution, Blank count = 
Background activity, 1000 = Conversion from ml to litres, Serum count = Activity in 
serum water, Urine count = Activity in zero urine water. 
 
Methanol was used for protein deposit in the bromide analysis whereupon the 
supernatant was extracted. The bromide concentration (mmol/L) was determined 
using a high performance liquid chromatography (HPLC). ECW, estimated as 
corrected bromide space (CBS) was calculated as (55):  
 
CBSBr (L) = 
Br dose
[Br serum]
 × 0.90 × 0.95 × 0.94    (2) 
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where Br dose = Amount of bromide (in mmol) in test solution administered, [Br 
serum] = Concentration (in mmol/L) bromide in serum, 0.90 = correction factor for 
bromide distribution in intracellular spaces, 0.95 = correction for the Gibbs-Donnan 
effect, 0.94 = correction factor for the concentration of water in serum.  
 
ICW was defined as (31): 
 
ICW(Dilution) (L) = TBW3H – ECWBr     (3) 
 
DXA. The DXA measurement was performed using a GE Lunar iDXA (enCORE, 
USA) whole body scanner, radiation dose 0.006mSv, measuring FM, lean soft tissue 
mass (LSTM) and bone mineral content (BMC).  
 
FFM was defined as (35):  
 
FFMDXA (kg) = LSTMDXA + BMCDXA    (4) 
 
TBSMM was calculated using a predictive model based on ALST (36): 
 
TBSMMDXA (kg) = 1.19 × ALSTDXA − 1.65     (5)  
 
SFB7. The measurement was performed right after the DXA measurement giving the 
subject a natural rest in supine position for 5-10 minutes. Four electrodes were 
positioned on the subject’s right side, two on the hand/wrist and two on the 
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foot/ankle. Values for TBW, ECW, ICW, FM and FFM were received using the 
proprietary software and equations of SFB7. 
 
TBSMM was calculated using a predictive model, developed in 75 year olds and 
derived from equation 5 above, according to equation 2 in Tengvall (40):   
TBSMMSFB7 (kg))= −23.953 + (0.333 × Ht) + (−0.004 × Ri) + (−0.010 × Re) + (−1.72
7 × gender) + (0.042 × BW)       (6) 
where Ri = intracellular fluid resistance, Re = extracellular fluid resistance, Ht =   
Height in cm, BW = Body Weight in kg, gender (women = 1; men = 0)    
Whole body counting for TBK. The laboratory is a room partly underground, shielded 
by iron ore concrete walls, floor and ceiling to reduce background radiation. A 
chamber made of plate armour and lead plates further surrounds the detector system 
and a bunk intended for the subject. The subjects were dressed in their underwear and 
a special coat, intended to avoid radiation (e.g. radon) from their own clothes. The 
subjects lay in the chamber for 300 s. The counts per second (CPS) from 40K, a 
radioactive isotope of natural body potassium were measured. TBK was calculated as:   
 
TBK (mmol) = CPS (
40K) × CF
1.195
       (7) 
where CF = Calibration Factor = 138 × BW/Ht + 66.5,  where BW = Body Weight in 
kg, Ht = Height in cm. The Calibration Factor was derived from measurements on 
plastic phantoms of various sizes, containing known amounts of 40K.  
 
BCM was calculated as (56): 
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BCMTBK (kg) = 0.00833 × TBK     (8) 
 
ICW was calculated as (38, 57): 
 
ICWTBK (L) = 0.70 × BCM/0.99371     (9) 
where 0.70 is the assumed proportion of water in BCM and 0.99371 is the	  density of 
water at 36°C. 	  
ADP. The subjects entered the ADP-device (BodPod, Cosmed, Italy), an ovoid 
chamber, measuring body volume, for 2 × 40 s. To reduce body surface area they 
wore only their underwear. A swim cap was used to reduce hair volume. An 
electronic balance determined their weight. By the density (mass/unit volume), the 
Siri Equation was used to calculate percent fat (58):     
 
Percent FatADP = 4.95/density – 4.50     (10) 
 
FM was derived from percent fat:  
 
FMADP (kg) = Percent fat/100 × BW     (11)   
where BW = Body Weight in kg 
Statistical methods and variable analyses 
Statistical analyses were performed using IBM® SPSS 24.0 for MAC (SPSS Inc., 
Chicago, IL, USA). Data were analysed in three parts: as a whole group (n=50) and 
divided by gender (male, n=25; female, n=25).  
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The number of subjects was equal to study populations used in previous similar 
research (43) , however limited by a late approval from the regional ethical review 
board in Gothenburg.  
 
Estimates from reference methods and SFB7 were compared using linear regression 
from which Pearson correlation (rP) was received. Paired-Samples T-Test’s were used 
to compare means between a reference method and SFB7 within each group. 
Independent-Samples T-Test’s were used to compare estimates between the female 
group and the male group. Bland Altman plots examined the difference in a variable 
measured with a reference method and SFB7 as a function of their mean. By using 
linear regression in the Bland Altman plots, systematic bias could be found. Statistical 
significance were equated with p-values < 0.05.  
 
Comparisons were made between: 
• TBSMM estimates by SFB7 and DXA 
• FM estimates by SFB7 and DXA 
• FM estimates by SFB7 and ADP 
• FM estimates by ADP and DXA 
• FFM estimates by SFB7 and DXA 
• TBW estimates by SFB7 and 3H-dilution 
• ECW estimates by SFB7 and Br-dilution 
• ICW estimates by SFB7 and Dilution Techniques  
• ICW estimates by SFB7 and TBK   
	   18	  
Data analysis 
A systematic inspection of manually entered data (Height, Body Weight, gender etc.) 
for each method was made ensuring correct measurements. Deviating values were 
identified by the minimum and maximum values in descriptive statistics (table 1) and 
by outliers and extremes in boxplots.  
 
Outliers were defined as values deviating > 1.5 interquartile ranges (IQR) from the 
end of the boxes. Extremes were defined as values deviating > 3 IQR from the end of 
the boxes. Variables used to identify outliers and extremes are presented in textbox 1.  
Textbox 1: Variables used to identify outliers and extremes.  
TBSMM measured by SFB7 and DXA 
FM measured by SFB7, DXA and ADP 
FFM measured by SFB7 and DXA 
TBW measured by SFB7 and 3H-dilution 
ECW measured by SFB7 and Br-dilution 
ICW measured SFB7 Dilution Techniques and TBK  
Difference in TBSMM (DXA-SFB7) 
Difference in FM (DXA-SFB7, ADP-SFB7) 
Difference in FFM (DXA-SFB7) 
Difference in TBW (3H-dilution - SFB7) 
Difference in ECW (Br-dilution - SFB7) 
Difference in ICW (Dilution Techniques-SFB7, TBK-SFB7)      
 
Outliers and extremes were examined in the whole group, male group and the female 
group.	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Ethics 
The study contributed to a greater insight for each subject regarding body 
composition. There were examples where the subject’s test results were not consistent 
with their own appreciation, e.g. regarding body fat. This could possibly result in 
negative alterations in self-image, eating habits and exercise. Furthermore, there was 
a risk to detect abnormal nutritional status or an illness. One subject had to recur for 
further investigations because of a tendency to low bone mineral density.  
 
The radiation dosage from the DXA (0.006mSv) and 3H-dilution (0.07mSv) 
measurement was less than the dosage from a dental X-ray, however not to be 
considered negligible. A few subjects found the blood and urine specimen collection 
unpleasant. The author underwent all the measurements.    
 
Data could be linked to the subjects only in connection with the measurements. 
Before data processing all names were replaced with a key. Informed consent was 
obtained from all participants.  
 
A medical doctor with specialized expertise in clinical nutrition reviewed all the 
measured values. Adequate follow-up was available in case of deviation. 
 
The regional ethical review board in Gothenburg (application number: 773-16) and 
the Radiation Protection Committee (application number: 16-43) in the Region of 
Västra Götaland approved this study.  
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Results 
There was no significant difference in age between the genders. The male group was 
taller, weighed more and had a larger BMI. For full descriptive statistic, see table 1. 
 
All 50 participants took part in all measurements. Due to technical errors 9 subjects 
repeated the TBK measurement and 2 subjects repeated the SFB7 measurement 
within a week from the original occasion. These were included. The systematic 
inspection of manually entered data and descriptive statistics (table 1) required no 
exclusion. 31 outliers and 6 extremes in 12 subjects were found. One female, who was 
an outlier in the “difference in ICW (TBK-SFB7)” variable and who repeated the 
TBK measurement at a different occasion was excluded in a recast of statistics 
regarding TBK. The remaining outliers and extremes were included.     
 
SFB7 measurements for each variable (TBSMM, FM, TBW, ECW and ICW) are 
further validated under separate subheadings.   
TBSMM estimates, a comparison between DXA and SFB7 
SFB7 underestimates mean TBSMM in comparison with DXA in all three groups 
(table 2). The underestimation was more pronounced in the male group than in the 
female group (p = 0.012).  
 
The correlation between DXATBSMM and SFB7TBSMM was high in the whole group (rP 
= 0.943, p < 0.001) and the male group (rP = 0.914, p < 0.001) but only moderate in 
the female group (rP = 0.572, p = 0.003) (table 2, figure 1).  
 
A systematic bias was found in both the whole group and the male group according to 
	   21	  
the linear regression in Bland Altman plot. The correlation was positive in both the 
whole group (rP = 0.450, p = 0.001) and the male group (rP = 0.779, p < 0.001), 
reflecting an increasing underestimation by SFB7 as mean TBSMM increases. No 
systematic bias was found in the female group (table 2, figure 2). 
FM estimates, a comparison between DXA, ADP and SFB7 
SFB7 underestimates mean FM in comparison with DXA in all three groups (table 3).  
There was no significant difference in mean FM between the genders (p = 0.444).   
 
The correlation between DXAFM and SFB7FM was high in the female group (rP = 
0.898, p <0.001), somewhat lower in the whole group (rP = 0.816, p < 0.001) and 
moderate in the male group (rP = 0.636, p = 0.001) (table 3, figure 3a-c). 
 
SFB7’s underestimation of FM in comparison with DXA was balanced by an 
overestimation of FFM (table 3). 
 
SFB7 underestimates mean FM in comparison with ADP in the whole group and the 
female group. There was no significant difference in mean FM between ADP and 
SFB7 in the male group. The correlation between ADPFM and SFB7FM was high in the 
female group (rP = 0.890, p < 0.001), moderate in the whole group (rP = 0.745, p < 
0.001) and low in the male group (0.408, p < 0.043) (table 3, figure 3d-f).  
 
No systematic bias was found in any of the groups, neither when comparing SFB7 to 
DXA or SFB7 to ADP, according to the linear regression in Bland Altman plot.  
However, a wide spread along the y-axis and a wide spread in the same vertical line is 
prominent in the plots, especially in the whole group and the male group (table 3, 
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figure 4). The wide spread in the same vertical line reflects how SFB7 both 
underestimates and overestimates FM by several kg among subjects with the 
approximate same amount of FM. 
 
The correlation between FM measured by the reference methods (ADP and DXA) 
was high in all three groups. However, ADP tends to provide lower estimates for FM 
than DXA. No systematic bias was found, according to the linear regression in Bland 
Altman plot (table 3). 
TBW estimates, a comparison between 3H-dilution and SFB7 
SFB7 slightly overestimates mean TBW in comparison with 3H-dilution in the whole 
group. In both the male group and the female group SFB7 mean difference for TBW 
were consistent with Dilution Techniques. The correlation between 3H-dilutionTBW 
and SFB7TBW was high in the whole group (rP = 0.958, p < 0.001), rather high in the 
male group (rP = 0.880, p < 0.001) but moderate in the female group (rP = 0.763, p < 
0.001) (table 4, figure 5).  
 
There was no systematic bias in any of the groups, according to the linear regression 
in Bland Altman plot. However, a wide spread along the y-axis and in the same 
vertical line is prominent in the plots (table 4, figure 6).  
ECW estimates, a comparison between Br-dilution and SFB7 
SFB7 overestimates mean ECW in comparison with Br-dilution in all three groups 
(table 5). The overestimation is more pronounced in the male group than in the 
female group (p < 0.001).  
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The correlation between Br-dilutionECW and SFB7ECW was high in all three groups 
(table 5, figure 7).  
 
A systematic bias was found in the whole group (rP = -0.790, p < 0.001) and the male 
group (rP = -0.487, p < 0.014), according to the linear regression in Bland Altman 
plot. The correlation was negative in the two groups, reflecting an increasing 
overestimation of ECW by SFB7 as mean ECW increases. No systematic bias was 
found in the female group (table 5, figure 8). 
ICW estimates, a comparison between Dilution Techniques and SFB7 and 
between TBK and SFB7 
Dilution-SFB7: SFB7 underestimates mean ICW in comparison with Dilution 
Techniques in the whole group and the male group. There was no significant 
difference in mean ICW between SFB7 and Dilution Techniques in the female group. 
The correlation was rather high in the whole group (rP = 0.884, p < 0.001) but 
moderate in the male group (rP = 0.667, p < 0.001) and the female group (rP = 0.548, 
p = 0.005) (table 6, figure 9a-c). 
 
A systematic bias was found in the whole group according to the linear regression in 
Bland Altman plot. The correlation was positive in the whole group (rP = 0.360, p = 
0.010), reflecting an increasing underestimation by SFB7 as mean ICW increases. No 
systematic bias was found in the male group and the female group. A wide spread 
along the y-axis and in the same vertical line is prominent in the plots in all three 
groups (table 6, fig. 10a-c).  
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TBK-SFB7: SFB7 overestimates mean ICW in comparison with TBK in the whole 
group and the female group while no significant difference in mean ICW was found 
in the male group. The correlation was high in the whole group (rP = 0.895, p < 
0.001) but moderate in the male group (rP = 0.745, p < 0.001), and the female group 
(rP = 0.507, p = 0.010) (table 6, fig. 9d-f). 
 
No systematic bias was found in any of the groups, according to the linear regression 
in Bland Altman plot, however a wide spread along the y-axis and in the same vertical 
line is prominent in the plots (table 6, fig. 10d-f).  
 
When excluding the subject who was an outlier and who repeated the TBK 
measurement at a different occasion, no significant difference in mean ICW between 
TBK and SFB7 occurred (whole group, p = 0.847; female group, p = 0.715) according 
to Independent-Samples T-Test. In both groups, the correlation between TBKICW and 
SFB7ICW improved slightly and as before the exclusion, no systematic bias was found 
(table 6).   
Discussion 
Findings 
We have validated SFB7’s ability to predict TBSMM, FM, TBW, ECW and ICW in a 
healthy study population. Unfortunately, this study shows a lack in SFB7’s ability to 
predict all these values in men, women and when combining the genders. 	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Adjacent studies 
The TBSMM equation for bioimpedance was derived from DXA-estimates. The 
equation was developed in 75 year olds from Sweden (n=98; men, n=50; women, 
n=48; medication use in 87/98). In comparison with our whole group (n=50) a similar 
correlation was found between TBSMM measured by DXA and bioimpedance (rPn=98 
= 0.96, rPn=50 = 0.943), however no systematic bias was found in the other study.  
Apart from the age difference, the latter could be explained by their use of a different 
bioimpedance analyser (Xitron Hydra 4200) and DXA-scanner (Lunar Prodigy) (40).    
 
Bioimpedance underestimating FM in comparison with DXA has been shown in a 
previous study with a slightly different population (Norwegian; n=93; men, n=57; 
women, n=36; age 51 ± 11.5 years; BMI 30.9 ± 4.5 kg/m2), using the same DXA but 
a different bioimpedance analyser (BodyScout). The difference in mean FM between 
DXA and bioimpedance was more pronounced in that study (Δmean FMn=93 = 4.1 ± 
3.6kg, Δmean FMn=50 = 2.8 ± 3.4kg) but they presented a higher correlation (rPn=93 = 
0.95, rPn=50 = 0.816). In contrast to our study, their difference in mean FM was 
significantly higher in the male group than in the female group and a systematic bias 
was found in the whole group.  The study concluded that the proprietary software of 
the bioimpedance device should not be used in estimation of body FM on an 
individual level (59).     
 
A previous study in healthy subjects (n=73, 36.2 ± 10.0 years) presented a similar 
correlation between ICW measured by TBK and bioimpedance (rPn=73 = 0.85; rPn=50 = 
0.895). However, their difference in mean ICW was more appealing (0.08 litres). The 
differences could be explained by their use of a different bioimpedance analyser 
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(Xitron 4000B), different gender distribution (63 men, 10 women), nationality 
(Italian) and probable differences in whole-Body Counting constructions and 
calibrations (44).    
 
A previous Dietary Thesis at the University of Gothenburg in Sweden (n=42, equal 
gender distribution, healthy subjects, age 47.4 ± 18.6 years) presented a similar 
correlation between TBW measured by 3H-dilution and bioimpedance (r2n=42 = 0.94; 
r2n=50 = 0.917; where r2 = rP squared) and ECW measured by Br-dilution and 
bioimpedance (r2n=42 = 0.93; r2n=50 = 0.914) but a higher correlation between ICW 
measured by Dilution Techniques and bioimpedance (r2n=42 = 0.90; r2n=50 = 0.781). 
They used the same Dilution Techniques as in our study. Bioimpedance 
overestimated FFM in comparison with DXA in our study, while no significant 
difference in mean FFM was found in their study. The correlation between DXAFFM 
and bioimpedanceFFM was similar (r2n=42 = 0.90; r2n=50 = 0.925). Differences could be 
explained by their use of a different bioimpedance analyser (Xitron Hydra 4200 
devices (Xitron Technologies, San Diego, USA) and DXA-scanner (Lunar progidy, 
GE Lunar Corp, Madison, USA) (43).   
Methodological considerations  
In reference to a high frequency of malnutrition (2-14) and fluid imbalance (22, 23) 
among hospitalized patients, this study is a relevant contribution to the pursuit of 
simpler methods to estimate body composition. The research questions were concise 
and designed to be answered with a simple yes or no. The accuracy in choice of 
reference methods and statistical analyses provides a high credibility to the answers. 
The study was performed in a controlled environment. Competent personnel with 
many years of experience in the field performed a key part of the measurements.  
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Strengths and Weaknesses 
One of the greatest strengths of this study was the usage of several reference methods 
and statistical analyses. Since the study population was evenly divided by gender, we 
were able to make proper comparisons in SFB7’s ability to determine body 
composition estimates between men and women. 
 
Considering weaknesses, the study population was very homogenous. A large part of 
the group had a great common interest in fitness, among them elite athletes on a 
national level. Higher correlation was often found in the whole group (n = 50) than in 
the gender groups (n = 25), indicating the need of a larger study population to validate 
SFB7’s ability to determine body composition estimates in men and women 
separately. Also, several subjects repeated the TBK and SFB7 measurement on a 
different occasion, during which time normal variations in body composition may 
have occurred, possibly resulting in inaccurate values.  
 
To further elucidate the value of bioimpedance in clinical settings it would have been 
of interest to compare devices from different brands and to use more accurate 
reference methods such as MRI-scans.    
Clinical significance and improvements 
Whether SFB7’s inability to predict body composition estimates lies within the 
software used to determine raw data (resistance, reactance) or the equations further 
used to predict body composition estimates or within both is for us impossible to say. 
Since we do not know the equations used to predict these values, speculations for 
improvements are difficult. A possibility is to use more individualized values for body 
density. Bioimpedance equations rely on an appreciated value for body density 
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(1.05g/ml). The ADP in this study provided values for body density extending from 
1.01 – 1.08g/ml, indicating room for improvement.      
 
An attempt to develop bioimpedance equations for TBW and ECW specific for elite 
athletes was made recently (60). Even though our study population should not be 
considered elite athletes, they sure differed from the general population regarding 
physical fit. Perhaps data collected in this study could underpin a cross-validation 
study focusing on developing bioimpedance equations specific for moderate fitness 
performers and athletes.     
 
The equation used to predict TBSMM (40) needs improvement to fit a wider 
population. Among its weaknesses is the simplification were a differentiating between 
men and women is made using only a constant (−1.727).  
 
Since SFB7 provides unsatisfying values in our healthy study population we cannot 
expect it to provide proper values in patients with additionally medication and 
diagnoses affecting fluid balance.     
 
Perhaps, as suggested by a recent study in peritoneal dialysis patients, we should 
apply caution, and not let bioimpedance replace our subjective assessment (61).  
Transferability to the ill 
The results from this study are not applicable to the ill, nor were they intended to. If 
SFB7 had provided more satisfying body composition estimates in our healthy study 
population, further research in the ill would have been of interest. Our homogenous, 
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young and healthy study population, including several lean and muscular subjects, is 
quite the opposite of the typical elderly patient. 
 
As known from previous research, muscle mass tend to decrease with age (62).  
When comparing TBSMM determined by equation 2 in Tengvall and SFB7 with 
TBSMM determined by DXA, a systematic bias was found in our whole group and 
male group reflecting a lack of precision in SBF7’s ability to determine TBSMM 
dependent on the subjects’ amount of muscle mass.  
 
TBW tends to decrease with age as well. Whether it is due to the loss of ICW and 
BCM, or ECW is controversial (63). However it may have an impact on the 
bioimpedance estimates. 
 
The elderly has an increased amount of Visceral Adipose Tissue (VAT) in 
comparison with the young (64), which may have an impact on the bioimpedance 
estimates for FM.   
 
Intermuscular Adipose Tissue (IMAT) increases in the elderly (65) which may affect 
the bioimpedance ability to estimate both TBSMM and FM. 
Conclusions and Implications 
SFB7’s proprietary software and equations does not provide values for FM, TBW, 
ECW and ICW consistent with reference methods in healthy subjects. Equation 2 in 
Tengvall applied on SFB7 does not correctly estimate TBSMM. 
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We are brought further away from the vision of a manageable method to detect 
deviant nutrition and fluid imbalance among hospitalized patients. Improvements of 
SFB7’s equations and equation 2 in Tengvall in general and/or development of more 
individualized equations are needed. The SFB7’s software should be reviewed.  
 
This underlines the need to scrutinize proprietary equation if possible, as these have a 
profound impact on the performance of the bioimpedance’s output. Thus, 
bioimpedance methods are not just population specific, but also device- and equation 
specific. 	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Populärvetenskaplig sammanfattning – (på svenska) 
Bestämning av muskelmassa, fettmassa och kroppsvatten. Är bioimpedans med 
Impedimed SFB7 överensstämmande med referensmetoder? 
 
Det är vanligt att patienter på sjukhus lider av undernäring och rubbad vätskebalans. 
Detta leder till längre vårdtider, sjukare patienter, högre vårdkostnader och i värsta 
fall döden.  
 
Bioimpedans mäter det elektriska motståndet i kroppen och härleder utifrån 
ekvationer värden för kroppens olika vattenrum (totalt vatten, vattnet utanför cellerna 
och vattnet inuti cellerna). Beroende på fabrikat kan även värden för fettmassa och 
muskelmassa erhållas. Det är en lätthanterlig och billig metod, där man likt vid en 
EKG-undersökning fäster elektroder till kroppen. Svar fås på bara några sekunder. 
Metoden skulle kunna vara till hjälp inom sjukvården för att identifiera patienter i 
behov av extra näring, vätsketerapi och vätskedrivande. 
 
Innan bioimpedans kan börja användas som rutin inom sjukvården krävs dock fler 
studier som utvärderar metoden gentemot referensmetoder. I vår studie lät vi 50 friska 
forskningspersoner, hälften män och hälften kvinnor, mäta sig med en bioimpedans-
apparat av modellen Impedimed SFB7 (härefter hänvisad till som SFB7) och 4 
referensmetoder under en och samma förmiddag. SFB7 ger värden för de olika 
vattenrummen samt fettmassa. För att få bioimpedans-värden även för muskelmassa 
använde vi en extern ekvation. Referensmetoderna bestod av följande:  
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• Dual-energy X-ray Absorptiometry (DXA), en röntgenundersökning som 
bland annat mäter fettmassa och muskelmassa.    
• Air Displacement Pletysmography (ADP), en kammare som med hjälp av 
tryckförändringar beräknar kroppens densitet och därifrån härleder värden för 
fettmassa. 
• Helkroppsräknare för totalkalium, en äldre teknik där kroppens radioaktivitet 
från kalium mäts med strålningsdetektorer i en kammare. Utifrån kroppens 
kaliuminnehåll kan vattnet inuti cellerna beräknas. 
• En utspädningsteknik där forskningspersonerna fick dricka tritium (som 
fördelar sig i totalt vatten) och bromid (som fördelar sig i vattnet utanför 
cellerna). Ämnenas koncentrationer analyserades därefter i ett blodprov varpå 
beräkningar för de olika vattenrummens volymer kunde göras.  
 
SFB7’s värden för fettmassa och de olika vattenrummen jämfördes med 
referensmetodernas motsvarande värden. Detsamma gällde för muskelmassan som 
SFB7 beräknade med hjälp av den externa ekvationen. Hur väl mätningarna stämde 
överens med varandra undersöktes med medelvärdesjämförelser och korrelation 
(sambandet mellan SFB7’s värden för en kroppskomponent och en referensmetods 
värden för samma komponent). Vidare undersöktes om SFB7 gjorde några 
systematiska fel beroende på hur mycket av en kroppskomponent 
forskningspersonerna hade. 
 
Resultaten var dock nedslående. SFB7 gav värden för både fettmassa och de olika 
vattenrummen, som med en eller flera statistiska metoder skiljde sig från 
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referensmetoderna på ett betydande sätt. Detsamma gällde de värden för muskelmassa 
som SFB7 tog fram med hjälp av den externa ekvationen.   
 
Förbättringar av SFB7’s mjukvara och/eller dess ekvationer, samt den externa 
ekvationen som användes för att beräkna muskelmassa krävs innan mätningar på både 
friska individer och patienter inom sjukvården är lämpligt. 
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Table 2: Difference in TBSMM estimates between DXA and SFB7, analysed with Paired-Samples T-Test, 
linear regression and Bland Altman plot with linear regression.   
  Difference in mean Linear regression 
in BA 
 n kg p1 rP p2 LoA rP p3 
TBSMM DXA-SFB7 
(whole group) 
50 2.9 ± 2.5 <0.001 0.943 <0.001 -1.9 – 7.8 0.450 0.001 
TBSMM DXA-SFB7 
(male) 
25 3.8 ± 2.2 <0.001 0.914 <0.001 -0.5 – 8.1 0.779 <0.001 
TBSMM DXA-SFB7 
(female) 
25 2.1 ± 2.5 <0.001 0.572 0.003 -2.8 – 6.9 -0.268 0.194 
Abbreviations; TBSMM, Total Body Skeletal Muscle Mass; DXA, Dual-energy X-ray Absorptiometry; 
SFB7, Impedimed SFB7 bioimpedance device; BA, Bland Altman plot   
Data presented as difference in mean in kg ± 1 Standard Deviation (SD), ± 1.96 SD Limits of Agreement 
(LoA) and Pearson correlation (rP)   
p1 = by Paired-Samples T-Test. p2 = by linear regression. p3 = by linear regression in Bland Altman plot 
Figure 1: Correlation between TBSMM in kg measured by DXA (y-axis) and SFB7 (x-axis). a = whole group, b = 
male group, c = female group. Black line, regression line.	  
Abbreviations; TBSMM, Total Body Skeletal Muscle Mass; SFB7, Impedimed SFB7 bioimpedance device; DXA, 
Dual-energy X-ray Absorptiometry  
 
 
Figure 2: Bland Altman Plots with linear regression displaying the relationship between difference in TBSMM 
(TBSMMΔ) and mean TBSMM (TBSMMx ̄), where TBSMMΔ = DXATBSMM-SFB7TBSMM, TBSMMx ̄ = (DXATBSMM 
+SFB7TBSMM)/2. a = whole group, b = male group, c = female group. Continuous horizontal line, difference in 
mean; crosshatched lines, difference in mean ± 1.96 SD, Limits of Agreement (LoA); grey line, regression line. 
Abbreviations; TBSMM, Total Body Skeletal Muscle Mass; SFB7, Impedimed SFB7 bioimpedance device; DXA, 
Dual-energy X-ray Absorptiometry 
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Figure 3: Correlation between FM measured by DXA (y-axis) and SFB7 (x-axis) (a-c) and by ADP (y-axis) and 
SFB7 (x-axis) (d-f). a,d = whole group, b,e = male group, c,f = female group. Black line, regression line.  
Abbreviations; FM; Fat Mass, SFB7, Impedimed SFB7 bioimpedance device; DXA, Dual-energy X-ray 
Absorptiometry; ADP, Air Displacement Plethysmography 
 
 
 
 
Figure 4: Bland Altman Plots with linear regression displaying the relationship between the difference in FM 
(FMΔ) and mean FM (FMx ̄), where FMΔ (a-c) = DXAFM-SFB7FM, FMΔ  (d-f) ADPFM-SFB7FM, FMx ̄ (a-c) = 
(DXAFM+SFB7FM)/2, FMx ̄ (d-f) = (ADPFM+SFB7FM)/2. a,d = whole group, b,e = male group, c,f = female group. 
Continuous horizontal line, difference in mean; crosshatched lines, difference in mean ± 1.96 SD, Limits of 
Agreement (LoA); grey line, regression line.  
Abbreviations; FM; Fat Mass, SFB7, Impedimed SFB7 bioimpedance device; DXA, Dual-Energy X-ray 
Absorptiometry; ADP, Air Displacement Plethysmography 
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Table 3: Difference in FM and FMM estimates between SFB7 and reference methods, analysed with Paired-
Samples T-Test, linear regression and Bland Altman plot with linear regression.   
  Difference in mean Linear regression in BA 
 n kg p1 rP p2 LoA rP p3 
FM DXA-SFB7 
(whole group) 
50 2.8 ± 3.4 <0.001 0.816 <0.001 -3.9 – 9.5 -0.126 0.385 
FM DXA-SFB7 
(male group) 
25 3.2 ± 4.0 0.001 0.636 0.001 -4.6 – 10.9 -0.047 0.824 
FM DXA-SFB7 
(female group) 
25 2.4 ± 2.9 <0.001 0.898 <0.001 -3.2 – 8.0 -0.165 0.431 
FM ADP-SFB7 
(whole group) 
50 1.2 ± 4.1 0.049 0.745 <0.001 -6.8 – 9.1 -0.082 0.573 
FM ADP-SFB7 
(male group) 
25 1.1 ± 5.0 0.289 0.408 0.043 -8.7 – 10.9 -0.059 0.779 
FM ADP-SFB7 
(female group) 
25 1.2 ± 3.0 0.047 0.890 <0.001 -4.6 – 7.1 -0.150 0.475 
FM ADP-DXA 
(whole group) 
50 -1.6 ± 1.7 <0.001 0.953 <0.001 -4.9 – 1.7 0.061 0.675 
FM ADP-DXA 
(male group) 
25 -2.1 ± 1.9 <0.001 0.907 <0.001 -5.9 – 1.7 -0.042 0.841 
FM ADP-DXA 
(female group) 
25 -1.2 ± 1.3 <0.001 0.979 <0.001 -3.6 – 1.3 0.021 0.921 
FFM DXA-SFB7 
(whole group) 
50 -2.0 ± 3.5 <0.001 0.962 <0.001 -8.8 – 4.8 -0.090 0.535 
FFM DXA-SFB7 
(male group) 
25 -2.2 ± 4.1 0.011 0.887 <0.001 -10.2 – 5.7 -0.035 0.868 
FFM DXA-SFB7 
(female group) 
25 -1.8 ± 2.8 0.004 0.786 <0.001 -7.4 – 3.8 -0.194 0.354 
Abbreviations; FM; Fat Mass, FFM; Fat Free Mass; SFB7, Impedimed SFB7 bioimpedance device; DXA, Dual-
energy X-ray Absorptiometry; ADP, Air Displacement Plethysmography; BA, Bland Altman plot 
Data presented as difference in mean in kg ± 1 Standard Deviation (SD), ± 1.96 SD Limits of Agreement (LoA) 
and Pearson correlation (rP)    
p1 = by Paired-Samples T-Test. p2 = by linear regression. p3 = by linear regression in Bland Altman plot     
Figure 5: Correlation between TBW in litres measured by Tritium dilution (y-axis) and SFB7 (x-axis). a = 
whole group, b = male group, c = female group. Black line, regression line.   
Abbreviations; TBW, Total Body Water; SFB7, Impedimed SFB7 bioimpedance device; 3H, Tritium dilution 
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Table 4:  Difference in TBW estimates between Tritium dilution and SFB7, analysed with Paired-Samples T-
Test, linear regression and Bland Altman plot with linear regression.     
  Difference in mean Linear regression in BA 
n litres p1 rP p2 LoA rP p3 
TBW 3H-SFB7 
(whole group) 
50 -0.8 ± 2.7 0.032 0.958 <0.001 -6.1 – 4.4 -0.072 0.619 
TBW 3H-SFB7 
(male group) 
25 -1.0 ± 3.0 0.110 0.880 <0.001 -7.0 – 5.0 -0.035 0.867 
TBW 3H-SFB7 
(female group) 
25 -0.7 ± 2.3 0.165 0.763 <0.001 -5.1 – 3.8 -0.009 0.966 
Abbreviations; TBW, total body water; SFB7, Impedimed SFB7 bioimpedance device; 3H, Tritium dilution; 
BA, Bland Altman plot 
Data presented as difference in mean in litres ± 1 Standard Deviation (SD), ± 1.96 SD Limits of Agreement 
(LoA) and Pearson correlation (rP) 
p1 = by Paired-Samples T-Test. p2 = by linear regression. p3 = by linear regression in Bland Altman plot   
Table 5:  Difference in ECW estimates between Bromide dilution and SFB7, analysed with Paired-Samples T-
Test, linear regression and Bland Altman plot with linear regression.   
  Difference in mean Linear regression in BA 
 n litres p1 rP p2 LoA rP p3 
ECW Br-SFB7 
(whole group) 
50 -1.9 ± 1.6 <0.001 0.956 <0.001 -5.1 – 1.2 -0.790 <0.001 
ECW Br-SFB7 
(male group) 
25 -3.3 ± 1.0 <0.001 0.931 <0.001 -5.3 – -1.2 -0.487  0.014 
ECW Br-SFB7 
(female group) 
25 -0.6 ± 0.6 <0.001 0.907 <0.001 -1.8 – 0.6 0.165 0.431 
Abbreviations; ECW, Extracellular Water: SFB7, Impedimed SFB7 bioimpedance device; Br, Bromide 
dilution; BA, Bland Altman plot 
Data presented as difference in mean in litres ± 1 Standard Deviation (SD), ± 1.96 SD Limits of Agreement 
(LoA) and Pearson correlation (rP) 
p1 = by Paired-Samples T-Test. p2 = by linear regression. p3 = by linear regression in Bland Altman plot    
Figure 6: Bland Altman Plots with linear regression displaying the relationship between difference in TBW 
(TBWΔ) and mean TBW (TBWx ̄), where TBWΔ = 3HTBW-SFB7TBW, TBWx ̄ = (3HTBW+SFB7TBW)/2. a = whole 
group, b = male group, c = female group. Continuous horizontal line, difference in mean; crosshatched lines, 
difference in mean ± 1.96 SD, Limits of Agreement (LoA); grey line, regression line.  
Abbreviations; TBW, Total Body Water; SFB7, Impedimed SFB7 bioimpedance device; 3H, Tritium dilution 
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Table 6: Difference in ICW estimates between Dilution Techniques and SFB7 and between TBK and SFB7, 
analysed with Paired-Samples T-Test, linear regression and Bland Altman plot with linear regression.    
 Difference in mean Linear regression in BA 
 n litres p1 rP p2 LoA rP p3 
ICW Dil-SFB7 
(whole group) 
50 1.1 ± 3.1 0.013 0.884 <0.001 - 4.9 – 7.1 0.360 0.010 
ICW Dil-SFB7 
(male group) 
25 2.3 ± 3.3 0.002 0.667 <0.001 -4.2 – 8.8 0.131 0.533 
ICW Dil-SFB7 
(female group) 
25 0.0 ± 2.3 0.934 0.548 0.005 -4.6 – 4.5 -0.075 0.723 
ICW TBK-SFB7 50 -1.6 ± 2.6 <0.001 0.895 <0.001 -6.7 – 3.5 0.151 0.295 
(whole group) 49* -1.7 ± 2.5 <0.001 0.901 <0.001 -6.6 – 3.3 0.211 0.146 
ICW TBK-SFB7 
(male group) 
25 -1.1 ± 2.9 0.074 0.745 <0.001 -6.7 – 4.5 0.073 0.729 
ICW TBK-SFB7 25 -2.1 ± 2.3 <0.001 0.507 0.010 -6.5 – 2.4 -0.268 0.196 
(female group) 24* -2.3 ± 2.0 <0.001 0.580 0.003 -6.3 – 1.7 -0.180 0.399 
Abbreviations; ICW, Intracellular Water; SFB7, Impedimed SFB7 bioimpedance device; Dil, Dilution 
Techniques; TBK, Total Body Potassium; BA, Bland Altman plot   
Data presented as difference in mean in litres ± 1 Standard Deviation (SD), Pearson correlation (rP), ± 1.96 
SD Limits of Agreement (LoA)  
p1 = by Paired-Samples T-Test. p2 = by linear regression. p3 = by linear regression in Bland Altman plot  
*One subject excluded due to repeated TBK measurement at a different occasion.   
Figure 8: Bland Altman Plots with linear regression displaying the relationship between difference in ECW 
(ECWΔ) and mean ECW (ECWx ̄), where ECWΔ = BrECW-SFB7ECW, ECWx ̄ = (BrECW +SFB7ECW)/2. a = whole 
group, b = male group, c = female group. Continuous horizontal line, difference in mean; crosshatched lines, 
difference in mean ± 1.96 SD, Limits of Agreement (LoA); grey line, regression line (hardly visible in c). 
Abbreviations; ECW, Extracellular Water; SFB7, Impedimed SFB7 bioimpedance device; Br, Bromide dilution 
 
 
 
  
 
 
 
 
Figure 7: Correlation between ECW in litres measured by SFB7 (x-axis) and Bromide dilution (y-axis). a = 
whole group, b = male group, c = female group. Black line, regression line.  
Abbreviations; ECW, Extracellular Water; SFB7, Impedimed SFB7 bioimpedance device; Br, Bromide dilution 
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Figure 9: Correlation between ICW in litres measured by SFB7 (x-axis) and Dilution Techniques (y-axis) (a-c) 
and by SFB7 (x-axis) and TBK (y-axis) (d-f). a,d = whole group, b,e = male group, c,f = female group. Black 
line, regression line.   
Abbreviations; ICW, Intracellular Water; SFB7, Impedimed SFB7 bioimpedance device; Dil, Dilution 
Techniques; TBK, Total Body Potassium   
 
 
Figure 10: Bland Altman plots with linear regression displaying the relationship between difference in ICW 
(ICWΔ) and mean ICW (ICWx ̄), where ICWΔ (a-c) = ICWDil-ICWSFB7, ICWΔ  (d-f) ICWTBK-ICWSFB7, ICWx ̄ (a-c) 
= (ICWDil+ICWSFB7)/2, ICWx ̄ (d-f) = (ICWTBK+ICWSFB7)/2. a,d = whole group, b,e = male group, c,f = female 
group. Continuous horizontal line, difference in mean; crosshatched lines, difference in mean ± 1.96 SD, Limits 
of Agreement (LoA); grey line, regression line.   
Abbreviations: ICW, Intracellular Water; SFB7, Impedimed SFB7 bioimpedance device; Dil, Dilution 
Techniques; TBK, Total Body Potassium  
  
 
 
